Google

MARF : Creating Hope For Patients and Their Families

By Teteh Neneng
Mesothelioma is an aggressive cancer caused by asbestos. For decades, asbestos was used heavily in construction, industry, the Navy, even household products and appliances. It is still present in many homes, schools, and office buildings. The disease can arise from small exposures, and even as much as 50 years later. As a result, each year 3,000 Americans and many thousands more worldwide develop mesothelioma, and millions of us are at risk.

The Meso Foundation is the non-profit collaboration of patients and families, physicians, advocates, and researchers dedicated to eradicating the life-ending and vicious effects of mesothelioma. We promote critically-needed research to develop more effective treatments and ultimately a cure! We have awarded over $4 million in grant funding, advancing meso science through promising studies around the world.

Through our Patient Advocacy program we also offer personalized help to patients and family members, educating them on the disease, helping them to obtain the most up-to-date information on treatment options, and connecting them with meso treatment specialists, and with other patients and families.

This site is another tool to give meso patients and their families the latest and most relevant information about the disease, offer hope and support, and unite the meso community. We encourage you to explore the various topics and search through our vast document archive. We invite you to join the Meso Community where you will be able to chat with other meso patients and their families and find valuable resources. Finally, we encourage you to contact our Patient Advocacy Director to get personalized assistance.

And now, Mesothelioma Applied Research Foundation (MARF) standing with us. Together creating hope for all mesothelioma patients, also hope for their families. You can get any information about MARF activity on www.marf.org

Tell this information to your friends, may be they need it.
 

0 comments so far.

Something to say?